GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4985)

  • GC70520 structure
    GC70520MIND4-17
    CAS: 345989-24-4
    Purity: >99.00%

    MIND4-17 ist ein potenter NRF2-Aktivator, der einen C151-Rückstand von Keap1 kovalent modifiziert.

  • GC70567 structure
    GC70567NecroX-7
    CAS: 1120332-55-9
    Purity: >99.00%

    NecroX-7 ist ein potenter Radikalfänger und ein HMGB1 (High-Mobility Group Box 1)-Inhibitor.

  • GC70570 structure
    GC70570RH01386
    CAS: 301177-36-6
    Purity: >99.00%

    RH01386 ist ein kleines Molekül, das endoplasmatische Retikulum Stress (ERS)-induzierte β-Zelldysfunktion und -tod verhindern kann und proapoptotische Genexpression hemmt.

  • GC70571 structure
    GC70571CP-312
    CAS: 895470-67-4
    Purity: >99.00%

    CP-312 ist ein starker Heme Oxygenase-1 (HO-1)-Induktor.

  • GC70584 structure
    GC70584Actinomycin X2
    CAS: 18865-48-0
    Purity: >98.00%

    Actinomycin X2 (Actinomycin V), produziert von vielen Streptomyces sp.

  • GC70612 structure
    GC70612Arochlor 1254
    CAS: 11097-69-1

    Arochlor 1254 ist ein polychloriertes Biphenyl (PCB)-Gemisch mit Biphenyl und 54% Chlor.

  • GC70659 structure
    GC706599-cis-Retinoic acid-d5
    Purity: >98.00%

    9-cis-Retinoic acid-d5 ist die Deuterium markierte 9-cis-Retinosäure.

  • GC70733 structure
    GC70733ABT-510 acetate
    CAS: 442526-87-6
    Purity: >99.00%

    ABT-510 acetate ist ein anti-angiogenes TSP-Peptid (Thrombospondin-1-Analogon), das Apoptose induziert und das Wachstum von Eierstocktumoren in einem orthotopischen syngenen Modell des epithelialen Eierstockkrebs hemmt.

  • GC70742 structure
    GC70742Betamethasone-d5-1
    CAS: 2244574-92-1

    βmethasone-d5-1 ist Deuterium mit Betamethason markiert.

  • GC70753 structure
    GC70753PDK4-IN-1
    CAS: 2310262-10-1
    Purity: >98.00%

    PDK4-IN-1 ist ein Anthrachinon-Derivat und ein potenter und oral aktiver Pyruvat-Dehydrogenase-Kinase-4 (PDK4)-Inhibitor mit einem IC50-Wert von 84 nM.

  • GC70756 structure
    GC70756Cytarabine-d2
    CAS: 40632-26-6
    Purity: >98.00%

    Cytarabine-d2 ist das Deuterium markierte Cytarabin.

  • GC70759 structure
    GC70759AQX-435
    CAS: 1619983-52-6
    Purity: >99.00%

    AQX-435 ist ein starker SHIP1-Phosphatase-Aktivator.

  • GC70768 structure
    GC70768BMS-986251
    CAS: 2460133-35-9

    BMS-986251 ist ein oral aktiver und selektiver RORγ inverser Agonist mit einem EC50 von 12 nM für RORγ GAL4.

  • GC70787 structure
    GC70787β-Aminoarteether
    CAS: 133162-24-0

    β-Aminoarteether (SM934 freie Basis) ist ein Artemisinin-Derivat mit oral aktiver Wirkung.

  • GC70853 structure
    GC70853Broussochalcone A
    CAS: 99217-68-2
    Purity: >97.00%

    Broussochalcone A ist ein Antioxidans und ein Inhibitor der Xanthinoxidase (IC50=2,21 μM), mit freier Radikalfängung.

  • GC70868 structure
    GC70868Nrf2 activator-3
    CAS: 2766570-23-2
    Purity: >98.00%

    Nrf2 activator-3 ist ein potenter Nrf2-Aktivator.

  • GC70953 structure
    GC70953α7 nAchR-JAK2-STAT3 agonist 1
    CAS: 2108714-20-9

    α7 nAchR-JAK2-STAT3 agonist 1 ist ein potenter α7 nAchR-JAK2-STAT3-Agonist mit einem IC50-Wert von 0,32 μM für Stickstoffmonoxid (NO).

  • GC70971 structure
    GC70971S-HP210
    Purity: >98.00%

    S-HP210 ist ein potenter und selektiver Glukokortikoidrezeptor (GR) mit einem IC50-Wert von 1,92 μM für NF-κB-Transrepression (TR).

  • GC70972 structure
    GC70972R-HP210
    Purity: >98.00%

    R-HP210 wirkt auf die NF-κB vermittelte tethered transrepression Funktion (IC50=3,80μM).

  • GC70979 structure
    GC70979Anti-inflammatory agent 38
    CAS: 3032633-42-1
    Purity: >98.00%

    Anti-inflammatory agent 38 (Verbindung 23d) ist ein potenter Nrf2/HO-1 Pathway Inhibitor mit einem IC50 Wert von 0,38 μM für NO.

  • GC70987 structure
    GC70987Avacincaptad pegol sodium
    CAS: 1491144-00-3
    Purity: >98.50%

    Avacincaptad pegol sodium ist ein Anti-C5-RNA-Aptamer, das die Spaltung des Komplementfaktors 5 (C5) in C5a und C5b hemmt.

  • GC71003 structure
    GC71003ALPK1-IN-1
    CAS: 2765457-72-3
    Purity: >99.00%

    ALPK1-IN-1 (Verbindung A001) ist ein starker Inhibitor der Alphakinase 1 (ALPK1).

  • GC71031 structure
    GC71031Nrf2 activator-6
    CAS: 2728780-74-1

    Nrf2 activator-6, eine Tetrahydroisochinolinverbindung, ist ein Nrf2-Aktivator.

  • GC71072 structure
    GC71072NXPZ-2
    CAS: 2254492-08-3
    Purity: >98.00%

    NXPZ-2 ist ein oral aktiver Keap1-Nrf2 Protein-Protein-Interaktionshemmer (PPI) mit einem Ki-Wert von 95 nM, EC50-Wert von 120 und 170 nM.